Fluoroquinolones are antibiotic medications, available only via prescription from a physician, used to treat bacterial infections such as pneumonia, urinary tract infections, sinus infections, etc. They are dispensed by pharmacies in pill form and taken orally by the patient, or administrated in medical facilities via injection.
On December 20, 2018, the FDA issued a safety communication regarding these antibiotic medications specific to an increased risk of ruptures or tears of the aorta blood vessel in certain patients. The safety communication from the FDA states: “FDA review found that fluoroquinolone antibiotics can increase the occurrence of rare but serious events of ruptures or tears in the main artery of the body, called the aorta.” Studies suggest that individuals who are prescribed fluoroquinolone are two times as likely to develop dangerous aortic conditions.
An aortic rupture occurs when there is a bulge in part of the aorta, the body’s main artery. The bulge can burst, resulting in severe blood loss, hospitalization, and even death. An aortic dissection is when the inner layer of the aorta tears, also resulting in severe blood loss and serious complications.
It is important to note that if you are currently taking Fluoroquinolone antibiotics, do not stop taking your medications without the advice and/or guidance of a physician. Patients should speak to their doctor immediately about any questions or concerns that they have regarding their medication treatment regimen.
If you or a loved one have experienced an aortic rupture or aortic dissection while taking Fluoroquinolone antibiotics, you may be eligible to file a claim. Attorneys at Kenneth S. Nugent, P.C. are currently investigating claims involving Fluoroquinolone antibiotics and are here to help you. We are currently accepting cases involving brand name versions of the medication fluoroquinolone, which includes Levaquin, Avelox, Factive, Baxdela, and Ofloxacin.
Click the chat bubble to send us a message or call us toll free at 1-888-579-1790.
For more information, and additional resources, visit: https://www.fda.gov/Drugs/DrugSafety/ucm628753.htm